About this event
The diversity across tumors from different patients and even across cancer cells from the same patient makes the picture very complex. The idea of ‘personalized’ or ‘precision’ medicine has been suggested, aiming to find tailored treatment regimen for each patient according to the individual genetic background and tumor molecular profile. This attempt is achievable thanks to sufficient molecular characterization of cancers accumulated using high-throughput technologies and advanced imaging technologies. However, despite availability of cancer multi-scale data, they are not fully exploited to provide the clue on deregulated mechanisms that would guide better patients stratification and to specific treatment in cancer.
- Registration deadline: August 25th 2021
- Please note that due to the current pandemic situation and strict regulations regarding face-to-face meetings, this will be a REAL-TIME VIRTUAL COURSE (Paris Time, GMT+1)
- This course is a FEBS-supported event